FBT logo

First Trust NYSE Arca Biotechnology Index Fund (FBT)

$266.86

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on FBT

AUM

$3.03B

P/E ratio

26.2

Dividend yield

--

Expense ratio

0.55%

Beta

0.675029

Price on FBT

Previous close

$266.97

Today's open

$265.78

Day's range

$264.03 - $267.39

52 week range

$189.47 - $283.21

Profile about FBT

show more

Headquarters

US

Exchange

NYSE Arca

Issue type

Exchange-Traded Fund

FBT industries and sectors

Industries

Health

Top holdings in FBT
News on FBT

Two Ways to Play Biotech: FBT's Return Edge vs. IBB's Cost Advantage

First Trust NYSE Arca Biotechnology Index Fund maintains a more concentrated portfolio of 30 holdings compared to the 243 positions found in iShares Biotechnology ETF. iShares Biotechnology ETF carries a lower expense ratio of 0.44% whereas First Trust NYSE Arca Biotechnology Index Fund charges 0.55%.

news source

The Motley Fool • Nov 14, 2026

news preview

Better Biotech ETF: First Trust's FBT vs. Invesco's PBE

The First Trust NYSE Arca Biotechnology Index Fund has a lower expense ratio and significantly higher assets under management (AUM). The First Trust NYSE Arca Biotechnology Index Fund outperformed the Invesco fund on a 1-year total return basis and over a five-year period.

news source

The Motley Fool • Nov 14, 2026

news preview

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Making its debut on 06/19/2006, smart beta exchange traded fund First Trust NYSE Arca Biotechnology ETF (FBT) provides investors broad exposure to the Health Care ETFs category of the market.

news source

Zacks Investment Research • Nov 11, 2026

news preview

Drug Makers or Biotech Bets: Which ETF Is the Better Buy, State Street's XPH or First Trust's FBT?

State Street SPDR S&P Pharmaceuticals ETF offers a lower expense ratio of 0.35% compared to 0.55% for the First Trust fund. First Trust NYSE Arca Biotechnology Index Fund has delivered higher total returns over the past one-year and five-year periods.

news source

The Motley Fool • Nov 11, 2026

news preview

Which Is the Better Buy: iShares' Pharma ETF IHE or First Trust's Biotech Fund FBT?

iShares U.S. Pharmaceuticals ETF has a lower expense ratio than the First Trust NYSE Arca Biotechnology Index Fund. First Trust NYSE Arca Biotechnology Index Fund maintains a more concentrated portfolio.

news source

The Motley Fool • Nov 11, 2026

news preview

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund launched on June 19, 2006.

news source

Zacks Investment Research • Nov 4, 2026

news preview

ETFs That You May Consider Amid a Strengthening Biotech Outlook

Drug innovation, AI and rising M&A activity are boosting biotech optimism. Discover ETFs offering exposure to the sector.

news source

Zacks Investment Research • Oct 28, 2026

news preview

Which Healthcare ETF Is the Better Buy: Simplify's Mission-Driven PINK or First Trust's Biotech FBT?

First Trust NYSE Arca Biotechnology Index Fund tracks a concentrated index of 30 biotech stocks, while Simplify Health Care ETF is an actively managed fund with broader healthcare exposure. Simplify Health Care ETF features a lower expense ratio and has experienced a significantly lower maximum drawdown over the last five years compared to the First Trust fund.

news source

The Motley Fool • Oct 27, 2026

news preview

Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT?

iShares Global Healthcare ETF offers a lower expense ratio and broader sector exposure than First Trust NYSE Arca Biotechnology Index Fund. First Trust NYSE Arca Biotechnology Index Fund focuses exclusively on biotechnology while iShares Global Healthcare ETF includes pharmaceuticals and equipment.

news source

The Motley Fool • Oct 26, 2026

news preview

Which Healthcare ETF Is the Better Buy: Invesco's Broad RSPH or First Trust's Biotech FBT?

First Trust NYSE Arca Biotechnology Index Fund has delivered significantly higher 1-year total returns but with greater volatility and a deeper maximum drawdown. Invesco S&P 500 Equal Weight Health Care ETF provides broader sector coverage, whereas the First Trust fund is a concentrated play on 30 biotechnology firms.

news source

The Motley Fool • Oct 26, 2026

news preview

¹ Disclosures

Get started with M1

Invest in First Trust NYSE Arca Biotechnology Index Fund

Open an M1 investment account to buy and sell First Trust NYSE Arca Biotechnology Index Fund commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in FBT on M1